37
In band
Moving averages
SMA 200$0.18-55.61%
Company profile
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company is headquartered in Weston, Florida.
SectorHealthcare
IndustryBiotechnology
Market cap$1.54M
P/E ratioNone
EPS$-4.18
Beta0.791
Dividend yield0.00%
52-week high$0.80
52-week low$0.11
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 48
VRTX
Vertex Pharmaceuticals Inc
RSI 46
CRSP
CRISPR Therapeutics AG
RSI 47
IOVA
Iovance Biotherapeutics Inc
RSI 73
MRNA
Moderna Inc
RSI 72
VKTX
Viking Therapeutics Inc
RSI 40
SRPT
Sarepta Therapeutics Inc
RSI 43
EDIT
Editas Medicine Inc
RSI 56
IBRX
ImmunityBio Inc
RSI 67
NVAX
Novavax Inc
RSI 68
RSI alerts for ZVSA
Get an email the moment ZyVersa Therapeutics Inc. crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 22 September 2026 at 12:46 AM EDT